glp 1 gip gcg receptor agonist GLP-1R, GIPR, and GCGR: Targets for Obesity and Diabetes Structural basis for the therapeutic

Clinically, as a prescriber of a variety of the GLP-1 medications, I can say that many patients on these medications have prior diagnoses of anxiety and/or depression, and a vast majority of patients who have seen positive results from these medications would report improvement in their depression and anxiety symptoms

Holman RR, et al

For study 1 (weight loss study of GLP-1MK-801 relative to monotherapies), mice were randomly divided into four experimental groups ( n = 8 mice per group) with similar mean body weights and assigned to receive once-daily s.c

However, this phosphorylation was blocked by the GLP-1-R-Antagonist Exendin(9-36), emphasizing the role of GLP-1-mediated signaling [16]